Campitelli, Maura
 Distribuzione geografica
Continente #
AS - Asia 890
NA - Nord America 875
EU - Europa 522
SA - Sud America 181
AF - Africa 41
OC - Oceania 2
Totale 2.511
Nazione #
US - Stati Uniti d'America 833
SG - Singapore 343
VN - Vietnam 169
CN - Cina 166
BR - Brasile 154
SE - Svezia 105
IT - Italia 97
DE - Germania 92
IN - India 64
FR - Francia 59
GB - Regno Unito 40
IE - Irlanda 26
FI - Finlandia 21
JP - Giappone 21
BD - Bangladesh 20
CA - Canada 19
HK - Hong Kong 19
MX - Messico 18
ID - Indonesia 17
RU - Federazione Russa 15
CI - Costa d'Avorio 13
IQ - Iraq 11
NL - Olanda 11
AR - Argentina 10
UA - Ucraina 9
BE - Belgio 8
ES - Italia 8
KR - Corea 8
ZA - Sudafrica 8
AT - Austria 6
CL - Cile 6
EC - Ecuador 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
IR - Iran 5
PK - Pakistan 5
TR - Turchia 5
BH - Bahrain 4
KE - Kenya 4
MA - Marocco 4
MT - Malta 4
PH - Filippine 4
PL - Polonia 4
CO - Colombia 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
JO - Giordania 3
KZ - Kazakistan 3
LT - Lituania 3
SN - Senegal 3
EG - Egitto 2
ET - Etiopia 2
JM - Giamaica 2
TN - Tunisia 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BY - Bielorussia 1
CH - Svizzera 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 2.511
Città #
Singapore 188
San Jose 95
Ashburn 94
Chandler 94
Beijing 63
Ho Chi Minh City 58
Hanoi 40
The Dalles 37
Los Angeles 35
New York 32
Rome 30
Dublin 26
Munich 25
Hefei 23
Lauterbourg 22
Frankfurt am Main 21
Hyderabad 21
Tokyo 21
Milan 19
Hong Kong 18
São Paulo 16
Jacksonville 15
Jakarta 15
St Louis 14
Abidjan 13
Ann Arbor 13
San Mateo 13
Da Nang 12
Boston 11
Bremen 11
Helsinki 11
Brooklyn 10
Moscow 10
Orem 10
Princeton 10
Wilmington 9
Dallas 8
London 8
Rio de Janeiro 8
Seoul 8
Brussels 7
Council Bluffs 7
Kent 7
Montreal 7
Buffalo 6
Chicago 6
Fairfield 6
Hải Dương 6
Marseille 6
Phoenix 6
Atlanta 5
Chennai 5
City of London 5
Dhaka 5
Guangzhou 5
Lappeenranta 5
Amsterdam 4
Augusta 4
Baghdad 4
Bắc Ninh 4
Cattolica 4
Dearborn 4
Denver 4
Düsseldorf 4
Falkenstein 4
Johannesburg 4
Mexico City 4
Nairobi 4
Nanjing 4
Nuremberg 4
Toronto 4
Turku 4
Washington 4
Addlestone 3
Almaty 3
Amman 3
Antalya 3
Belo Horizonte 3
Bengaluru 3
Bismarck 3
Biên Hòa 3
Blida 3
Cambridge 3
Curitiba 3
Dakar 3
Dubai 3
Haiphong 3
Hortolândia 3
Houston 3
Kish 3
Nanchang 3
Ninh Bình 3
North Bergen 3
Ottawa 3
Paola 3
Poplar 3
Querétaro 3
Redwood City 3
San Francisco 3
Santa Clara 3
Totale 1.430
Nome #
Evaluation of early regression index as response predictor in cervical cancer: A retrospective study on T2 and DWI MR images 185
The role of 18F-FDG-PET/CT in predicting the histopathological response in locally advanced cervical carcinoma treated by chemo-radiotherapy followed by radical surgery: a prospective study 144
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures 140
Cervical cancer patterns of care in Italy: A radiation oncology survey of MITO and AIRO GYN groups 137
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures 135
Recurrent Endometrial Cancer: Which Is the Best Treatment? Systematic Review of the Literature 132
EROS study: Evaluation between high-dose-rate and low-dose-rate vaginal interventional radiotherapy (brachytherapy) in terms of overall survival and rate of stenosis 131
Standardized data collection to build prediction models in oncology: A prototype for rectal cancer 130
DW-MRI predictive factors for radiation-induced vaginal stenosis in patients with cervical cancer 125
Low Tesla magnetic resonance guided radiotherapy for locally advanced cervical cancer: first clinical experience 123
Efficacy of stereotactic body radiotherapy and response prediction using artificial intelligence in oligometastatic gynaecologic cancer 117
Machine-learning prediction of treatment response to stereotactic body radiation therapy in oligometastatic gynecological cancer: A multi-institutional study 110
Real-world outcomes of PARP inhibitor maintenance in advanced ovarian cancer: a focus on disease patterns and treatment modalities at recurrence 108
Efficacy and Safety of Stereotactic Body Radiation Therapy in Oligometastatic Uterine Cancer (MITO-RT2/RAD): A Large, Real-World Study in Collaboration With Italian Association of Radiation Oncology, Multicenter Italian Trials in Ovarian Cancer, and Mario Negri Gynecologic Oncology Group Groups 106
EROS 2.0 study: evaluation of two interventional radiotherapy (brachytherapy) schedules for endometrial cancer: a comparison of late vaginal toxicity rates 105
REPeated mAgnetic resonance Image-guided stereotactic body Radiotherapy (MRIg-reSBRT) for oligometastatic patients: REPAIR, a mono-institutional retrospective study 105
The role of 18F-FDG-PET/CT in predicting the histopathological response in locally advanced cervical carcinoma treated by chemo-radiotherapy followed by radical surgery: a prospective study 102
Locoregional pain treatment. Troubles and prospectives: antalgic radiotherapy 96
Hybrid MRI guided radiotherapy in locally advanced cervical cancer: Case report of an innovative personalized therapeutic approach 95
Neoadjuvant Chemoradiotherapy With Simultaneous Integrated Boost in Locally Advanced Cervical Cancer: Long Term Results of a Single-Center Experience 89
Stereotactic Body Radiation Therapy for Oligoprogressive Ovarian Cancer Patients Treated During Poly(ADP-Ribose)-Polymerase Inhibitor Maintenance: Efficacy and Adverse Events From the Epimetheo Retrospective Study 44
Treatment of Oligometastatic Parenchymal Lesions in Ovarian Cancer With Stereotactic Ablative Radiation Therapy: A Multicenter Prospective Phase 2 Trial (MITO RT3/RAD) 33
Stereotactic body radiotherapy and poly (ADP-ribose) polymerase inhibitors in ovarian cancer: a knowledge and attitudes survey in collaboration with the Italian Association of Radiation Oncology (AIRO) and Multicenter Italian Trials in Ovarian Cancer (MITO) groups 29
Stereotactic Ablative Radiation Therapy for Oligometastatic Ovarian Cancer Lymph Node Disease: The MITO-RT3/RAD Phase II Trial 25
Totale 2.546
Categoria #
all - tutte 9.518
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.518


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117 0 0 0 0 0 0 0 0 0 6 11 0
2021/2022115 14 3 2 14 4 2 0 25 7 7 21 16
2022/2023314 29 32 21 54 15 34 20 15 36 44 10 4
2023/2024183 6 46 19 16 9 26 13 4 2 4 16 22
2024/2025467 7 7 22 12 43 9 28 17 62 60 112 88
2025/20261.322 160 50 71 192 211 92 270 87 109 80 0 0
Totale 2.546